Anton Roth
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Biochemistry top 5%
- Blood transfusion and management
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 3
- Metal complexes synthesis and properties 3
-
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Krsto Kolarić (21 shared papers)Marek Pawlicki (2 shared papers)Semiglazov Vf (1 shared paper)Konstantinas Povilas Valuckas (1 shared paper)Brian Leyland‐Jones (1 shared paper)Э К Возный (1 shared paper)Els Vercammen (1 shared paper)George Manikhas (1 shared paper)
- Journals
- Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Oncology (2 papers)Tumori Journal (13 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- SloveniaUnited StatesPoland
In The Last Decade
Anton Roth
23 papers receiving 877 citations
Anton Roth's Hit Papers
Peers
Comparison fields: 5 of 75
- Hematology 455
- Biochemistry 106
- Oncology 363
- Genetics 118
- Health Informatics 10
Countries citing papers authored by Anton Roth
This map shows the geographic impact of Anton Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Roth more than expected).
Fields of papers citing papers by Anton Roth
This network shows the impact of papers produced by Anton Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Roth. The network helps show where Anton Roth may publish in the future.
Co-authors
The 24 scholars most cited alongside Anton Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study Hit paper breakdown → | 2005 | 505 |
| 2 | 1983 | 102 | |
| 3 | 1986 | 45 | |
| 4 | 1980 | 44 | |
| 5 | 1976 | 43 | |
| 6 | 1999 | 24 | |
| 7 | 1977 | 21 | |
| 8 | 1980 | 20 | |
| 9 | 1982 | 20 | |
| 10 | 1984 | 20 | |
| 11 | 1997 | 14 | |
| 12 | 1978 | 14 | |
| 13 | 1987 | 14 | |
| 14 | 1985 | 13 | |
| 15 | 1983 | 8 | |
| 16 | 1990 | 6 | |
| 17 | 1981 | 6 | |
| 18 | 1986 | 4 | |
| 19 | 1980 | 4 | |
| 20 | 1984 | 3 |
About Anton Roth
Anton Roth is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 935 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Lung Cancer Treatments and Mutations (4 papers), Esophageal Cancer Research and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Metal complexes synthesis and properties (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Breast Cancer Treatment Studies (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Hematology (455 citations), Biochemistry (106 citations), Oncology (363 citations), Genetics (118 citations) and Health Informatics (10 citations). Anton Roth has collaborated with scholars based in Slovenia, United States and Poland. Frequent co-authors include Krsto Kolarić, Marek Pawlicki, Semiglazov Vf, Konstantinas Povilas Valuckas, Brian Leyland‐Jones, Э К Возный, Els Vercammen, George Manikhas, José Baselga and Xiangyang Liu. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Oncology, Tumori Journal and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.